Neumann, S.
Taylor, J.
Bamford, A.
Metcalfe, C.
Gaunt, D. M.
Whone, A.
Steeds, D.
Emmett, S. R.
Hollingworth, W.
Ben-Shlomo, Y.
Henderson, E. J. http://orcid.org/0000-0002-0016-1870
Funding for this research was provided by:
Health Technology Assessment Programme (HTA 16/31/13)
Article History
Received: 11 August 2021
Accepted: 4 October 2021
First Online: 29 October 2021
Declarations
:
: Ethical approval for the trial was granted from the Central Bristol Research Ethics Committee on 17th of May 2019 with reference 19/SW/0043, the Health Regulatory Authority on 26th July 2019, and the Medicines and Healthcare Regulatory Agency (MHRA) on 28th June 2019. All participants will be providing informed consent prior to participation. A copy of the consent form is provided in Additional fileInternalRef removed.
: Not applicable as study protocol.
: EJH has received funding from the National Institute of Health Research, Parkinson’s UK, The Gatsby Foundation and The British Geriatrics Society and has received fees and / or travel support from Bial, Abbvie, Luye and Profile, Ever, and Kyowa Kirin.